DUBLIN, Calif.--(BUSINESS WIRE)--AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, today announced its results for the second quarter ended June 30, 2022.
Blair LaCorte, Chief Executive Officer of AEye, said, “We achieved significant progress strengthening our platform to drive long-term growth and are pleased with our performance during the second quarter. Our industry leading technology, talented team, and strong reputation continue to position us as a leader in the lidar market. This momentum is reflected in the progress we are making in the auto market, as well as new market segments including our recent partnership with Booz Allen to support productization for defense applications.”
“While supply chain disruption and inflationary challenges continue to impact the industry and broader economy, we are confident that our innovative, capital-light, and high margin business model will enable us to achieve future growth. We remain encouraged with the traction we have gained, and are excited for what has yet to come,” concluded LaCorte.
Q2 2022 Financials
- Revenue of $0.7 million in the second quarter of 2022.
- GAAP net loss was $(26.5) million in the second quarter of 2022, or $(0.17) per share based on 157.3 million weighted average shares outstanding.
- Non-GAAP net loss was $(19.8) million in the second quarter of 2022, or $(0.13) per share based on 157.3 million weighted average shares outstanding.
- Cash, cash equivalents, and marketable securities were $125.8 million as of June 30, 2022. This excludes up to $123.6 million in available liquidity from our Common Stock Purchase Agreement.
Conference Call and Webcast Details
AEye management will hold a conference call today, August 15, 2022, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results. AEye CEO Blair LaCorte and CFO Bob Brown will host the call, followed by a question-and-answer session.
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
The call is also accessible via telephone through the following details:
Dial in Information:
- Participant Toll-Free Dial-In Number: 844-763-8274
- Participant International Dial-In Number: 412-717-9224
About AEye
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, logistics, and off-highway applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most; delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Japan, Korea, and the United States.
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to investors for a more consistent basis of comparison and to help investors evaluate the results of the Company’s on-going operations, and to help enable more meaningful period-to-period comparison. Non-GAAP financial measures are presented only as supplemental information for the purpose of understanding the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.
This presentation includes non-GAAP financial measures, including:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to filing Registration Statements on Form S-1, plus stock issuance costs, plus change in fair value of embedded derivative and warrant liabilities, less the gain on PPP loan forgiveness; and
- Adjusted EBITDA which is defined as non-GAAP net loss plus amortization and depreciation expense, plus interest expense and other, less interest income and other, plus provision for income tax expense.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about AEye’s products, the Company’s progress in commercialization, the potential of new market segments, and expected future results, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that AEye’s entrance into new markets or continued end-market momentum will provide a foundation for sustainable growth to the extent anticipated or in the timeframe contemplated, or at all; (ii) the risks that the significant progress strengthening AEye’s platform to drive long-term growth will continue to the extent anticipated or in the timeframe contemplated, or at all; (iii) the risks that AEye’s technology will not lead the industry in the short or long term, or both, due to competition, internal challenges, or both, such that AEye is unable to establish or maintain a position as a leader in the lidar market; (iv) the risks that AEye may not be able to successfully navigate either or both of the supply chain disruptions it faces or the inflationary challenges that currently exist and which may continue for a time period that is longer than anticipated, or is more severe than contemplated; (v) the risks that AEye’s innovative, capital-light, and high margin business model will not enable AEye to achieve future growth to the extent anticipated or in the timeframe contemplated, or at all; (vi) the risks that the traction gained by AEye to date will translate into future growth, revenue, or profitability to the extent anticipated or in the timeframe contemplated, or at all; (vii) the risks that AEye will be unable to strengthen its competitive position or deliver on its key objectives in 2022 due to supply chain disruptions, economic uncertainties, or otherwise; (viii) the risks that competing technologies will improve over time to become operationally equivalent or more cost-effective, or both, as compared to AEye’s product offering; (ix) the risks that competitors may introduce products with similar capabilities to AEye’s products and such competitive products are able to take some or all of the market share away from AEye; (x) the risks that AEye’s products will not meet the diverse range of performance and functional requirements of AEye’s target markets and customers; (xi) the risks that AEye’s products will not function as anticipated by AEye or by AEye’s target markets and customers; (xii) the risks that the size of the total available market for the use of lidar will be smaller than predicted or take longer to come to fruition than predicted; (xiii) the risk that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xiv) changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xv) the risks that AEye is unable to adequately implement its business plans, forecasts, and other expectations, and identify and realize additional opportunities; and (xvi) the risks of downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by the COVID-19 pandemic, including the Delta and Omicron variants, as well as future variants and subvariants, which has caused significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Quarterly Report on Form 10-Q that AEye has most recently filed with the U.S. Securities and Exchange Commission, or the SEC, and other documents filed by us or that will be filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.
Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.
| AEYE, INC. Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
||||||
|
June 30, 2022 | December 31, 2021 | ||||
|
||||||
ASSETS |
||||||
Current Assets: |
||||||
Cash and cash equivalents |
$ |
4,236 |
|
$ |
14,183 |
|
Marketable securities |
|
121,526 |
|
|
149,824 |
|
Accounts receivable, net |
|
189 |
|
|
4,222 |
|
Inventories, net |
|
5,066 |
|
|
4,085 |
|
Prepaid and other current assets |
|
4,151 |
|
|
5,051 |
|
Total current assets |
135,168 |
|
177,365 |
|
||
Right-of-use assets |
16,186 |
|
- |
|
||
Property and equipment, net |
6,717 |
|
5,129 |
|
||
Restricted cash |
2,150 |
|
2,150 |
|
||
Other noncurrent assets |
1,098 |
|
1,509 |
|
||
Total assets |
$ | 161,319 |
|
$ | 186,153 |
|
|
||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
||||||
Current Liabilities: |
||||||
Accounts payable |
$ | 3,836 |
|
$ | 2,542 |
|
Accrued expenses and other current liabilities |
10,792 |
|
8,739 |
|
||
Contract liabilities |
1,633 |
|
2,287 |
|
||
Total current liabilities |
16,261 |
|
13,568 |
|
||
Operating lease liabilities, noncurrent |
17,424 |
|
- |
|
||
Deferred rent, noncurrent |
- |
|
3,032 |
|
||
Other noncurrent liabilities |
46 |
|
786 |
|
||
Total liabilities |
33,731 |
|
17,386 |
|
||
Stockholders’ Equity (Deficit): |
||||||
Preferred stock |
- |
|
- |
|
||
Common stock |
16 |
|
16 |
|
||
Additional paid-in capital |
332,344 |
|
320,937 |
|
||
Accumulated other comprehensive loss |
(1,629 |
) |
(391 |
) |
||
Accumulated deficit |
(203,143 |
) |
(151,795 |
) |
||
Total stockholders’ equity (deficit) |
127,588 |
|
168,767 |
|
||
Total liabilities and stockholders’ equity (deficit) |
$ | 161,319 |
|
$ | 186,153 |
|
| AEYE, INC. Condensed Consolidated Statements of Operations (In thousands, except share and per share data) (Unaudited) |
|||||||||||||
|
Three months ended June 30, | Six months ended June 30, | |||||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||||||
|
|||||||||||||
Revenue: |
|||||||||||||
Prototype sales |
$ | 195 |
|
$ | 228 |
|
$ | 530 |
|
$ | 461 |
|
|
Development contracts |
511 |
|
519 |
|
1,258 |
|
615 |
|
|||||
Total revenues |
706 |
|
747 |
|
1,788 |
|
1,076 |
|
|||||
Cost of revenue |
1,427 |
|
454 |
|
2,909 |
|
1,071 |
|
|||||
Gross profit (loss) |
(721 |
) |
293 |
|
(1,121 |
) |
5 |
|
|||||
|
|||||||||||||
Operating Expenses: |
|||||||||||||
Research and development |
10,762 |
|
5,726 |
|
19,338 |
|
11,562 |
|
|||||
Sales and marketing |
5,323 |
|
1,911 |
|
9,939 |
|
3,498 |
|
|||||
General and administrative |
9,827 |
|
4,750 |
|
21,157 |
|
7,760 |
|
|||||
Total operating expenses |
25,912 |
|
12,387 |
|
50,434 |
|
22,820 |
|
|||||
Loss from operations |
(26,633 |
) |
(12,094 |
) |
(51,555 |
) |
(22,815 |
) |
|||||
|
|||||||||||||
Other income (expense), net: |
|||||||||||||
Change in fair value of embedded derivative liability and warrant liabilities |
141 |
|
(16 |
) |
109 |
|
(119 |
) |
|||||
Gain on PPP loan forgiveness |
- |
|
2,297 |
|
- |
|
2,297 |
|
|||||
Interest income and other |
350 |
|
2 |
|
774 |
|
5 |
|
|||||
Interest expense and other |
(307 |
) |
(1,264 |
) |
(650 |
) |
(1,952 |
) |
|||||
Total other income (expense), net |
184 |
|
1,019 |
|
233 |
|
231 |
|
|||||
Provision for income tax expense |
18 |
|
- |
|
26 |
|
- |
|
|||||
Net loss |
$ | (26,467 |
) |
$ | (11,075 |
) |
$ | (51,348 |
) |
$ | (22,584 |
) |
|
|
|||||||||||||
Per Share Data |
|||||||||||||
Net loss per common share (basic and diluted) |
$ | (0.17 |
) |
$ | (0.11 |
) |
$ | (0.33 |
) |
$ | (0.22 |
) |
|
Weighted average common shares outstanding (basic and diluted) |
157,310,419 |
|
101,458,886 |
|
156,071,676 |
|
101,398,851 |
|
|||||
| AEYE, INC. Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
||||||
|
Six Months Ended June 30, | |||||
|
2022 |
2021 |
||||
|
||||||
Cash flows from operating activities: |
||||||
Net loss |
$ | (51,348 |
) |
$ | (22,584 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||
Depreciation and amortization |
463 |
|
498 |
|
||
Noncash lease expense relating to operating lease right-of-use assets |
654 |
|
- |
|
||
Inventory write-downs, net of scrapped inventory |
335 |
|
- |
|
||
Change in fair value of embedded derivative liability and warrant liabilities |
(109 |
) |
119 |
|
||
Noncash gain on PPP loan forgiveness |
- |
|
(2,297 |
) |
||
Stock-based compensation |
11,897 |
|
4,230 |
|
||
Amortization of debt issuance costs |
- |
|
437 |
|
||
Amortization of debt discount |
- |
|
543 |
|
||
Amortization of premiums on marketable securities, net of change in accrued interest |
826 |
|
- |
|
||
Other |
- |
|
189 |
|
||
Changes in operating assets and liabilities: |
||||||
Accounts receivable, net |
4,033 |
|
18 |
|
||
Inventories, net |
(1,316 |
) |
(1,813 |
) |
||
Prepaid and other current assets |
900 |
|
(316 |
) |
||
Other noncurrent assets |
411 |
|
(144 |
) |
||
Accounts payable |
932 |
|
1,513 |
|
||
Accrued expenses and other current liabilities |
1,354 |
|
1,953 |
|
||
Operating lease liabilities |
(859 |
) |
- |
|
||
Deferred rent |
- |
|
(297 |
) |
||
Contract liabilities |
(1,285 |
) |
(388 |
) |
||
Net cash used in operating activities |
(33,112 |
) |
(18,339 |
) |
||
Cash flows from investing activities: |
||||||
Purchase of property and equipment |
(1,759 |
) |
(245 |
) |
||
Proceeds from redemption of marketable securities |
26,234 |
|
- |
|
||
Net cash provided by (used in) operating activities |
24,475 |
|
(245 |
) |
||
Cash flows from financing activities: |
||||||
Proceeds from exercise of stock options |
668 |
|
89 |
|
||
Proceeds from the issuance of convertible notes |
- |
|
8,045 |
|
||
Proceeds from bank loan |
- |
|
10,000 |
|
||
Principal payments - bank loan |
- |
|
(667 |
) |
||
Payment of deferred financing costs |
- |
|
(1,287 |
) |
||
Payment of debt issuance costs |
- |
|
(717 |
) |
||
Taxes paid related to the net share settlement of equity awards |
(3,400 |
) |
- |
|
||
Proceeds from issuance of common stock under the Common Stock Purchase Agreement |
1,422 |
|
- |
|
||
Net cash provided by (used in) financing activities |
(1,310 |
) |
15,463 |
|
||
Net decrease in cash and cash equivalents and restricted cash |
(9,947 |
) |
(3,121 |
) |
||
Cash, cash equivalents and restricted cash at beginning of period |
16,333 |
|
16,497 |
|
||
Cash, cash equivalents and restricted cash at end of period |
$ | 6,386 |
|
$ | 13,376 |
|
| AEYE, INC. Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands, except share and per share data) (Unaudited) |
|||||||||||||||
|
Three months ended June 30, | Six months ended June 30, | |||||||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||||||||
GAAP net loss |
$ | (26,467 |
) |
$ | (11,075 |
) |
$ | (51,348 |
) |
$ | (22,584 |
) |
|||
Non-GAAP adjustments: |
|||||||||||||||
Stock-based compensation |
6,557 |
|
2,620 |
|
11,897 |
|
4,230 |
|
|||||||
Expenses related to registration statement on Form S-1s |
250 |
|
425 |
|
250 |
|
425 |
|
|||||||
Change in fair value of embedded derivative and warrant liabilities |
(141 |
) |
16 |
|
(109 |
) |
119 |
|
|||||||
Stock issuance costs |
28 |
|
- |
|
28 |
|
- |
|
|||||||
Gain on PPP Loan Forgiveness |
- |
|
(2,297 |
) |
- |
|
(2,297 |
) |
|||||||
Non-GAAP net loss |
$ | (19,773 |
) |
$ | (10,311 |
) |
$ | (39,282 |
) |
$ | (20,107 |
) |
|||
Depreciation and amortization expense |
255 |
|
253 |
|
463 |
|
498 |
|
|||||||
Interest income and other |
(350 |
) |
(2 |
) |
(774 |
) |
(5 |
) |
|||||||
Interest expense and other |
279 |
|
1,264 |
|
622 |
|
1,952 |
|
|||||||
Provision for income tax expense |
18 |
|
- |
|
26 |
|
- |
|
|||||||
Adjusted EBITDA |
$ | (19,571 |
) |
$ | (8,796 |
) |
$ | (38,945 |
) |
$ | (17,662 |
) |
|||
|
|||||||||||||||
GAAP net loss per share attributable to common stockholders: |
|||||||||||||||
Basic and diluted |
$ | (0.17 |
) |
$ | (0.11 |
) |
$ | (0.33 |
) |
$ | (0.22 |
) |
|||
Non-GAAP net loss per share attributable to common stockholders: |
|||||||||||||||
Basic and diluted |
$ | (0.13 |
) |
$ | (0.10 |
) |
$ | (0.25 |
) |
$ | (0.20 |
) |
|||
Shares used in computing GAAP net loss per share attributable to common stockholders: |
|||||||||||||||
Basic and diluted |
157,310,419 |
|
101,458,886 |
|
156,071,676 |
|
101,398,851 |
|
|||||||
Shares used in computing Non-GAAP net loss per share attributable to common stockholders: |
|||||||||||||||
Basic and diluted |
157,310,419 |
|
101,458,886 |
|
156,071,676 |
|
101,398,851 |
|
|||||||
